The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
Network medicine framework for identifying drug-repurposing opportunities for COVID-19
Open accessAbstract
Significance: The COVID-19 pandemic has highlighted the importance of prioritizing approved drugs to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. Here, we deployed algorithms relying on artificial intelligence, network diffusion, and network proximity to rank 6,340 drugs for their expected efficacy against SARS-CoV-2. We experimentally screened 918 drugs, allowing us to evaluate the performance of the existing drug-repurposing methodologies, and used a consensus algorithm to increase the accuracy of the predictions. Finally, we screened in human cells the top-ranked drugs, identifying six drugs that reduced viral infection, four of which could be repurposed to treat COVID-19. The developed strategy has significance beyond COVID-19, allowing us to identify drug-repurposing candidates for neglected diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This evaluation method aligns with the approach predominantly used in the literature12,14–16,18–20.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [16]
Experimental — accuracy not yet measuredIn the citing paper
“The clinical utility of drug-repurposing artificial intelligence (AI) models remains limited because these models focus narrowly on diseases for which some drugs already exist.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [16]
In the citing paper
“Unfortunately, the ability of existing machine learning models to identify therapeutic candidates for diseases with incomplete, sparse data and zero-known therapies drops drastically16,22 (as we demonstrate across eight benchmarks in Fig. 2c,d).”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [16]
In the citing paper
“To provide therapeutic predictions, geometric deep-learning models optimized on large medical KGs15 can match disease signatures to therapeutic candidates based on networks perturbed in disease15–18.”
From A foundation model for clinician-centered drug repurposing (2024) · cites this paper as [16]
In the citing paper
“Graph representation learning has been successful in characterizing drugs at the systems level without patient data to make predictions about interactions with other drugs, protein targets, side effects, diseases [6, 38, 39, 40, 48, 165].”
From Graph representation learning in biomedicine and healthcare (2022) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Adam: A Method for Stochastic Optimization
Kingma, D. P., & Ba, J. (2014) · arXiv · doi:10.48550/arxiv.1412.6980 · Cited by 98,946
Scikit-learn: Machine Learning in Python
Pedregosa, F., Varoquaux, G., Gramfort, A., Michel, V., Thirion, B., Grisel, O., Blondel, M., Müller, A., Nothman, J., Louppe, G., et al. (2012) · arXiv · doi:10.48550/arxiv.1201.0490 · Cited by 71,016
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
(2014) · Cited by 33,419
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Graph Attention NetworksPreprint
Veličković, P., Casanova, A., Liò, P., Cucurull, G., Romero, A., & Bengio, Y. (2017) · arXiv (Cornell University) · doi:10.17863/cam.48429 · Cited by 19,745
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
(2010) · Cited by 14,134
Veličković, P., Cucurull, G., Casanova, A., Romero, A., Liò, P., & Bengio, Y. (2017) · arXiv · doi:10.48550/arxiv.1710.10903 · Cited by 12,107
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Inductive Representation Learning on Large Graphs
Hamilton, W. L., Ying, R., & Leskovec, J. (2017) · arXiv · doi:10.48550/arxiv.1706.02216 · Cited by 10,639
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
DrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., Chang, J., Hong, C., Zhou, Y., Wang, D., et al. (2020) · JAMA Neurology · doi:10.1001/jamaneurol.2020.1127 · Cited by 7,166
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hú, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,994
Divergence measures based on the Shannon entropy
Lin, J.-H. (1991) · IEEE Transactions on Information Theory · doi:10.1109/18.61115 · Cited by 5,877
Neural Message Passing for Quantum ChemistryPreprint
Gilmer, J., Schoenholz, S. S., Riley, P. F., Vinyals, O., & Dahl, G. E. (2017) · arXiv (Cornell University) · doi:10.48550/arxiv.1704.01212 · Cited by 5,678
Grasselli, G., Zangrillo, A., Zanella, A., Antonelli, M., Cabrini, L., Castelli, A., Cereda, D., Coluccello, A., Foti, G., Fumagalli, R., et al. (2020) · JAMA · doi:10.1001/jama.2020.5394 · Cited by 5,469
Dimensionality reduction for visualizing single-cell data using UMAP
Becht, E., McInnes, L., Healy, J., Dutertre, C.-A., Kwok, I. W. H., Ng, L. G., Ginhoux, F., & Newell, E. W. (2019) · Nature Biotechnology · doi:10.1038/nbt.4314 · Cited by 5,358
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Dose-Response Analysis Using R
Ritz, C., Baty, F., Streibig, J. C., & Gerhard, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0146021 · Cited by 3,833
A Next Generation Connectivity Map: L1000 Platform and the First 1,000,000 Profiles
Subramanian, A., Narayan, R., Corsello, S. M., Peck, D. D., Natoli, T. E., Lu, X., Gould, J., Davis, J. F., Tubelli, A. A., Asiedu, J. K., et al. (2017) · Cell · doi:10.1016/j.cell.2017.10.049 · Cited by 3,515
PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
Hornbeck, P. V., Zhang, B., Murray, B., Kornhauser, J. M., Latham, V., & Skrzypek, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1267 · Cited by 3,411
COVID-19 and the cardiovascular system
Zheng, Y.-Y., Ma, Y.-T., Zhang, J.-Y., & Xie, X. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-020-0360-5 · Cited by 2,970
Zhang, H., Penninger, J. M., Li, Y., Zhong, N., & Slutsky, A. S. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-05985-9 · Cited by 2,684
On the Surprising Behavior of Distance Metrics in High Dimensional Space
Aggarwal, C. C., Hinneburg, A., & Keim, D. A. (2001) · Lecture notes in computer science · doi:10.1007/3-540-44503-x_27 · Cited by 2,179
Rank aggregation methods for the Web
Dwork, C., Kumar, R., Naor, M., & Sivakumar, D. (2001) · International World Wide Web Conference (WWW) · doi:10.1145/371920.372165 · Cited by 1,825
Yıldırım, M. A., Goh, K.-I., Cusick, M. E., Barabási, A.-Ĺ., & Vidal, M. (2007) · Nature Biotechnology · doi:10.1038/nbt1338 · Cited by 1,744
Self-citationPredicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,623
Uncovering disease-disease relationships through the incomplete interactome
Menche, J., Sharma, A., Kitsak, M., Ghiassian, S. D., Vidal, M., Loscalzo, J., & Barabási, A.-L. (2015) · Science · doi:10.1126/science.1257601 · Cited by 1,546
Self-citationModeling polypharmacy side effects with graph convolutional networks
Zitnik, M., Agrawal, M., & Leskovec, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty294 · Cited by 1,501
Ritz, C., & Streibig, J. C. (2005) · Journal of Statistical Software · doi:10.18637/jss.v012.i05 · Cited by 1,456
Architecture of the human interactome defines protein communities and disease networks
Huttlin, E. L., Bruckner, R. J., Paulo, J. A., Cannon, J. R., Ting, L., Baltier, K., Colby, G., Gebreab, F., Gygi, M. P., Parzen, H., et al. (2017) · Nature · doi:10.1038/nature22366 · Cited by 1,437
Giacomelli, A., Pezzati, L., Conti, F., Bernacchia, D., Siano, M., Oreni, L., Rusconi, S., Gervasoni, C., Ridolfo, A. L., Rizzardini, G., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa330 · Cited by 1,326
A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances
Hein, M. Y., Hubner, N. C., Poser, I., Cox, J., Nagaraj, N., Toyoda, Y., Gak, I. A., Weisswange, I., Mansfeld, J., Buchholz, F., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.053 · Cited by 1,270
InnateDB: systems biology of innate immunity and beyond—recent updates and continuing curation
Breuer, K., Foroushani, A. B. K., Laird, M. R., Chen, C. C. L., Sribnaia, A., Lo, R., Winsor, G. L., Hancock, R. E. W., Brinkman, F. S. L., & Lynn, D. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1147 · Cited by 1,253
Drug target identification using side-effect similarity
Campillos, M., Kuhn, M., Gavin, A.-C., Jensen, L. J., & Bork, P. (2008) · Science · doi:10.1126/science.1158140 · Cited by 1,248
A reference map of the human binary protein interactome
Luck, K., Kim, D.-K., Lambourne, L., Spirohn, K., Begg, B. E., Bian, W., Brignall, R., Cafarelli, T., Campos-Laborie, F. J., Charloteaux, B., et al. (2020) · Nature · doi:10.1038/s41586-020-2188-x · Cited by 1,197
MINT, the molecular interaction database: 2012 update
Licata, L., Briganti, L., Peluso, D., Perfetto, L., Iannuccelli, M., Galeota, E., Sacco, F., Palma, A., Nardozza, A. P., Santonico, E., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr930 · Cited by 1,062
The Drug Repurposing Hub: a next-generation drug library and information resource
Corsello, S. M., Bittker, J. A., Liu, Z., Gould, J., McCarren, P. R., Hirschman, J., Johnston, S. E., Vrcic, A., Wong, B., Khan, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4306 · Cited by 1,028
The BioGRID interaction database: 2017 update
Chatr‐aryamontri, A., Oughtred, R., Boucher, L., Rust, J., Chang, C., Kolas, N. K., O’Donnell, L., Oster, S. K., Theesfeld, C. L., Sellam, A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1102 · Cited by 985
Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, ChinaPreprint
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Yu, T., Xie, C., Ma, K., Shang, K., Wang, W., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3541136 · Cited by 898
Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing
Riva, L., Yuan, S., Yin, X., Martin‐Sancho, L., Matsunaga, N., Pache, L., Burgstaller-Muehlbacher, S., Jesus, P. D. D., Teriete, P., Hull, M. V., et al. (2020) · Nature · doi:10.1038/s41586-020-2577-1 · Cited by 829
Network-based prediction of drug combinations
Cheng, F., Kovács, I. A., & Barabási, A.-Ĺ. (2019) · Nature Communications · doi:10.1038/s41467-019-09186-x · Cited by 819
Self-citationMémoire sur les élections au scrutin
Daunou, P. C. F. (1803) · Medical Entomology and Zoology · Cited by 814
A Dynamic Network Approach for the Study of Human Phenotypes
Hidalgo, C. A., Blumm, N., Barabási, A.-Ĺ., & Christakis, N. A. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000353 · Cited by 684
Self-citationZitnik, M., Nguyen, F., Wang, B., Leskovec, J., Goldenberg, A., & Hoffman, M. M. (2019) · Information Fusion · doi:10.1016/j.inffus.2018.09.012 · Cited by 675
Network-based in silico drug efficacy screening
Guney, E., Menche, J., Vidal, M., & Barábasi, A.-L. (2016) · Nature Communications · doi:10.1038/ncomms10331 · Cited by 625
A scored human protein–protein interaction network to catalyze genomic interpretation
Li, T., Wernersson, R., Hansen, R. B., Horn, H., Mercer, J., Slodkowicz, G., Workman, C. T., Rigina, O., Rapacki, K., Stærfeldt, H., et al. (2016) · Nature Methods · doi:10.1038/nmeth.4083 · Cited by 613
Computational Repositioning of the Anticonvulsant Topiramate for Inflammatory Bowel Disease
Dudley, J. T., Sirota, M., Shenoy, M. M., Pai, R. K., Roedder, S., Chiang, A. P.-F., Morgan, A. A., Sarwal, M., Pasricha, P. J., & Butte, A. J. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002648 · Cited by 604
Voting schemes for which it can be difficult to tell who won the election
Bartholdi, J. J., Tovey, C. A., & Trick, M. A. (1989) · Social Choice and Welfare · doi:10.1007/bf00303169 · Cited by 556
Network-based approach to prediction and population-based validation of in silico drug repurposing
Cheng, F., Desai, R. J., Handy, D. E., Wang, R., Schneeweiss, S., Barabási, A.-L., & Loscalzo, J. (2018) · Nature Communications · doi:10.1038/s41467-018-05116-5 · Cited by 552 · cited 2×
“(1) First, it uses the current aggregated ranking R to update the importance weights K r for each ranked list.”
MethodSelf-citationHIPPIE v2.0: enhancing meaningfulness and reliability of protein–protein interaction networks
Alanis‐Lobato, G., Andrade-Navarro, M. A., & Schaefer, M. H. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw985 · Cited by 541
Panorama of ancient metazoan macromolecular complexes
Wan, C., Borgeson, B., Phanse, S., Tu, F., Drew, K., Clark, G. W., Xiong, X., Kagan, O., Kwan, J., Bezginov, A., et al. (2015) · Nature · doi:10.1038/nature14877 · Cited by 522
The implications of human metabolic network topology for disease comorbidity
Lee, D., Park, J., Kay, K. A., Christakis, N. A., Oltvai, Z. N., & Barabási, A.-Ĺ. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802208105 · Cited by 495
Self-citationInteractome3D: adding structural details to protein networks
Mosca, R., Céol, A., & Aloy, P. (2013) · Nature Methods · doi:10.1038/nmeth.2289 · Cited by 479
HINT: High-quality protein interactomes and their applications in understanding human disease
Das, J., & Yu, H. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-92 · Cited by 462
GNNExplainer: Generating Explanations for Graph Neural Networks.
Ying, R., Bourgeois, D., You, J., Žitnik, M., & Leskovec, J. (2019) · PubMed · Cited by 424
Gordon, D. E., Jang, G. Μ., Bouhaddou, M., Xu, J., Obernier, K., O’Meara, M. J., Guo, J. Z., Swaney, D. L., Tummino, T. A., Hüttenhain, R., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.03.22.002386 · Cited by 419
PINA v2.0: mining interactome modules
Cowley, M. J., Pinese, M., Kassahn, K. S., Waddell, N., Pearson, J. V., Grimmond, S. M., Biankin, A. V., Hautaniemi, S., & Wu, J. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr967 · Cited by 353
Fiolet, T., Guihur, A., Rebeaud, M. E., Mulot, M., Peiffer‐Smadja, N., & Mahamat‐Saleh, Y. (2020) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2020.08.022 · Cited by 309
The Genotype-Tissue Expression (GTEx) project
Lonsdale, J., Thomas, J., Salvatore, M., Phillips, R., Lo, E., Shad, S., Hasz, R., Walters, G., Garcia, F., Young, N., et al. (2013) · Nature Genetics · doi:10.1038/ng.2653 · Cited by 263
The impact of cellular networks on disease comorbidity
Park, J. M., Lee, D., Christakis, N. A., & Barabási, A.-Ĺ. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.16 · Cited by 248
Self-citationFrom single drug targets to synergistic network pharmacology in ischemic stroke
Casas, A. I., Hassan, A., Larsen, S. J., Gómez‐Rangel, V., Elbatreek, M. H., Kleikers, P. W. M., Güney, E., Egea, J., López, M. G., Baumbach, J., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820799116 · Cited by 243
Settling the score: variant prioritization and Mendelian disease
Eilbeck, K. L., Quinlan, A. R., & Yandell, M. D. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2017.52 · Cited by 230
Molecular networks in Network Medicine: Development and applications
Silverman, E. K., Schmidt, H. H. H. W., Anastasiadou, E., Altucci, L., Angelini, M., Badimón, L., Balligand, J., Benincasa, G., Capasso, G., Conte, F., et al. (2020) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1489 · Cited by 218
Self-citationA genome-wide positioning systems network algorithm for in silico drug repurposing
Cheng, F., Lu, W., Liu, C., Fang, J., Hou, Y., Handy, D. E., Wang, R., Zhao, Y., Yang, Y., Huang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10744-6 · Cited by 215
Self-citationReilly, B. (2002) · International Political Science Review · doi:10.1177/0192512102023004002 · Cited by 214
SignaLink 2 – a signaling pathway resource with multi-layered regulatory networks
Fazekas, D., Koltai, M., Türei, D., Módos, D., Pálfy, M., Dúl, Z., Zsákai, L., Szalay-Bekő, M., Lenti, K., Farkas, I. J., et al. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-7 · Cited by 198
Sharma, A., Menche, J., Huang, C., Ort, T., Zhou, X., Kitsak, M., Sahni, N., Thibault, D. M., Voung, L., Guo, F., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv001 · Cited by 191
Self-citationAggregating inconsistent information
Ailon, N., Charikar, M., & Newman, A. (2005) · ACM Symposium on Theory of Computing (STOC) · doi:10.1145/1060590.1060692 · Cited by 187
Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing
Sadegh, S., Matschinske, J., Blumenthal, D. B., Galindez, G., Kacprowski, T., List, M., Nasirigerdeh, R., Oubounyt, M., Pichlmair, A., Rose, T. D., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17189-2 · Cited by 182
Predicting New Indications for Approved Drugs Using a Proteochemometric Method
Dakshanamurthy, S., Issa, N. T., Assefnia, S., Seshasayee, A., Peters, O. J., Madhavan, S., Üren, A., Brown, M. L., & Byers, S. W. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300576q · Cited by 177
Embedding Logical Queries on Knowledge Graphs
Hamilton, W. L., Bajaj, P., Zitnik, M., Jurafsky, D., & Leskovec, J. (2018) · arXiv · doi:10.48550/arxiv.1806.01445 · Cited by 176
Interactome INSIDER: a structural interactome browser for genomic studies
Meyer, M. J., Beltrán, J. F., Liang, S., Fragoza, R., Rumack, A., Liang, J. H., Wei, X., & Yu, H. (2018) · Nature Methods · doi:10.1038/nmeth.4540 · Cited by 157
APID database: redefining protein–protein interaction experimental evidences and binary interactomes
Alonso-López, D., Campos-Laborie, F., Gutiérrez, M. A., Lambourne, L., Calderwood, M., Vidal, M., & Rivas, J. D. L. (2019) · Database J. Biol. Databases Curation · doi:10.1093/database/baz005 · Cited by 152
INstruct: a database of high-quality 3D structurally resolved protein interactome networks
Meyer, M. J., Das, J., Wang, X., & Yu, H. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt181 · Cited by 144
Proteome-Scale Human Interactomics
Luck, K., Sheynkman, G., Zhang, I., & Vidal, M. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.02.006 · Cited by 142
Cao, M., Zhang, H., Park, J., Daniels, N. M., Crovella, M. E., Cowen, L. J., & Hescott, B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076339 · Cited by 131
Ordering by weighted number of wins gives a good ranking for weighted tournaments
Coppersmith, D., Fleischer, L., & Atri Rudra, B. (2006) · Symposium on Discrete Algorithms · doi:10.5555/1109557.1109642 · Cited by 125
do Valle, Í. F., Roweth, H. G., Malloy, M. W., Moco, S., Barron, D., Battinelli, E. M., Loscalzo, J., & Barabási, A.-Ĺ. (2021) · Nature Food · doi:10.1038/s43016-021-00243-7 · Cited by 120
Self-citationViral Perturbations of Host Networks Reflect Disease Etiology
Gulbahce, N., Yan, H., Dricot, A., Padi, M., Byrdsong, D., Franchi, R., Lee, D., Rozenblatt–Rosen, O., Mar, J. C., Calderwood, M. A., et al. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002531 · Cited by 110
Self-citationCuring a viral infection by targeting the host: The example of cyclophilin inhibitors
Lin, K. W., & Gallay, P. A. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.020 · Cited by 108
Cheng, F., Jia, P., Wang, Q., & Zhao, Z. (2014) · Oncotarget · doi:10.18632/oncotarget.1984 · Cited by 105
Interactome-based approaches to human disease
Caldera, M., Buphamalai, P., Müller, F., & Menche, J. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.04.015 · Cited by 104
Repurposing Auranofin, Ebselen, and PX-12 as Antimicrobial Agents Targeting the Thioredoxin System
May, H. C., Yu, J., Guentzel, M. N., Chambers, J. P., Cap, A. P., & Arulanandam, B. P. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00336 · Cited by 82
Prioritizing network communities
Žitnik, M., Sosič, R., & Leskovec, J. (2018) · Nature Communications · doi:10.1038/s41467-018-04948-5 · Cited by 72
Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records
Paik, H., Chung, A.-Y., Park, H., Park, R. W., Suk, K., Kim, J., Kim, H., Lee, K., & Butte, A. J. (2015) · Scientific Reports · doi:10.1038/srep08580 · Cited by 66
Buchanan, M., Buchanan, M., Caldarelli, G., Rios, P. L. D., Rao, F. V., & Vendruscolo, M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511845086 · Cited by 63
Ellinger, B., Bojková, D., Zaliani, A., Cinatl, J. J., Claussen, C., Westhaus, S., Reinshagen, J., Kuzikov, M., Wolf, M., Geißlinger, G., et al. (2020) · doi:10.21203/rs.3.rs-23951/v1 · Cited by 63
A large-scale benchmark of gene prioritization methods
Guala, D., & Sonnhammer, E. L. L. (2017) · Scientific Reports · doi:10.1038/srep46598 · Cited by 53
Pathway and network-based strategies to translate genetic discoveries into effective therapies
Greene, C. S., & Voight, B. F. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw160 · Cited by 52
Assessing Robustness of Intrinsic Tests of Independence in Two-Way Contingency Tables
Casella, G., & Moreno, E. (2009) · Journal of the American Statistical Association · doi:10.1198/jasa.2009.tm08106 · Cited by 47
A Survey of Gene Prioritization Tools for Mendelian and Complex Human Diseases
Zolotareva, O., & Kleine, M. (2019) · Journal of Integrative Bioinformatics · doi:10.1515/jib-2018-0069 · Cited by 46
Patten, J. J., Keiser, P. T., Gysi, D. M., Menichetti, G., Mori, H., Donahue, C. J., Gan, X., do Valle, Í. F., Geoghegan-Barek, K. M., Anantpadma, M., et al. (2022) · SSRN Electronic Journal · doi:10.1101/2021.04.20.440626 · Cited by 10
Self-citation
Cited by
Sorted by citations
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Scientific discovery in the age of artificial intelligence.
Wang, H., Fu, T., Du, Y., Gao, W., Huang, K., Liu, Z., Chandak, P., Liu, S., Van Katwyk, P., Deac, A., et al. (2023) · Nature · doi:10.1038/s41586-023-06221-2 · Cited by 1,823
Artificial intelligence in COVID-19 drug repurposing
Zhou, Y., Wang, F., Tang, J., Nussinov, R., & Cheng, F. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30192-8 · Cited by 636
Building a knowledge graph to enable precision medicine
Chandak, P., Huang, K., & Zitnik, M. (2023) · Scientific Data · doi:10.1038/s41597-023-01960-3 · Cited by 522
Self-citation
Metadata
- Authors
- Morselli Gysi, D., do Valle, Í., Zitnik, M., Ameli, A., Gan, X., Varol, O., Ghiassian, S. D., Patten, J. J., Davey, R. A., Loscalzo, J., & Barabási, A.-L.
- Affiliations
- Network Science Institute, Northeastern University, Boston, MA 02115;
- Department of Biomedical Informatics, Harvard University, Boston, MA 02115;
- Northeastern University (US)
- Brigham and Women's Hospital (US)
- Data Science Department, Scipher Medicine, Waltham, MA 02453;
- Boston University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2021-04-27
- Volume
- 118
- Issue
- 19
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W3017271475
- Cited by
- 107
- References
- 100
- Citations by year
- 2025: 5 · 2024: 6 · 2023: 16 · 2022: 15 · 2021: 47
- FWCI
- 11.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion, cc-by)
- PubMed (publishedVersion)
- arXiv (Cornell University) (submittedVersion)
- Europe PMC (PubMed Central) (submittedVersion, cc-by-nc-sa)
- Sabanci University (submittedVersion)
- Open Research (Auckland University of Technology) (submittedVersion, cc-by)
- arXiv (Cornell University)
- Funders
- American Heart Association
- National Institutes of Health (HL 108630)
- National Heart, Lung, and Blood Institute (P01HL132825, R01HL155096, U54HL119145, U01HL108630, R01HL155107)
- National Human Genome Research Institute (U01HG007690)
- National Institute of Allergy and Infectious Diseases (R01AI128364, R01AI125453, P01AI120943, UC7AI095321)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Keywords
- COVID-19 pandemic, SARS-CoV-2, drug repurposing, network medicine, drug prioritization, network diffusion, network proximity, consensus forecasts, antiviral drug discovery, neglected diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
